Responses
Other content recommended for you
- Intravenous immunoglobulin response in treatment - naïve chronic inflammatory demyelinating polyradiculoneuropathy
- Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies
- Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy
- Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment
- Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses
- Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1
- Different electrophysiological profiles and treatment response in ‘ typical ’ and ‘ atypical ’ chronic inflammatory demyelinating polyneuropathy
- Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
- Chronic inflammatory demyelinating polyradiculoneuropathy presenting as predominantly sciatic monomelic neuropathy
- Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP